Study on the activity of non-purine xanthine oxidase inhibitor by 3D-QSAR modeling and molecular docking

被引:17
作者
Li, Peizhen [1 ]
Tian, Yueli [1 ]
Zhai, Honglin [1 ]
Deng, Fangfang [1 ]
Xie, Meihong [1 ]
Zhang, Xiaoyun [1 ]
机构
[1] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China
基金
中国国家自然科学基金;
关键词
Xanthine oxidase; Non-purine xanthine oxidase inhibitors; CoMFA; CoMSIA; Molecular docking; FREE-RADICALS; DERIVATIVES; OXIDOREDUCTASE; HYPERURICEMIA; ALLOPURINOL; REGRESSION; DISCOVERY; PYRAZOLE; GOUT;
D O I
10.1016/j.molstruc.2013.07.043
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Non-purine derivatives have been shown to be promising novel drug candidates as xanthine oxidase inhibitors. Based on three-dimensional quantitative structure-activity relationship (3D-QSAR) methods including comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), two 3D-QSAR models for a series of non-purine xanthine oxidase (XO) inhibitors were established, and their reliability was supported by statistical parameters. Combined 3D-QSAR modeling and the results of molecular docking between non-purine xanthine oxidase inhibitors and XO, the main factors that influenced activity of inhibitors were investigated, and the obtained results could explain known experimental facts. Furthermore, several new potential inhibitors with higher activity predicted were designed, which based on our analyses, and were supported by the simulation of molecular docking. This study provided some useful information for the development of non-purine xanthine oxidase inhibitors with novel structures. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 30 条
[1]   Progress towards the discovery of xanthine oxidase inhibitors [J].
Borges, F ;
Fernandes, E ;
Roleira, F .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :195-217
[2]   Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives [J].
Chimenti, F ;
Bizzarri, B ;
Manna, F ;
Bolasco, A ;
Secci, D ;
Chimenti, P ;
Granese, A ;
Rivanera, D ;
Lilli, D ;
Scaltrito, MM ;
Brenciaglia, MI .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) :603-607
[3]   Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives [J].
Congiu, Cenzo ;
Onnis, Valentina ;
Vesci, Loredana ;
Castorina, Massimo ;
Pisano, Claudio .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) :6238-6248
[4]   CROSS-VALIDATION, BOOTSTRAPPING, AND PARTIAL LEAST-SQUARES COMPARED WITH MULTIPLE-REGRESSION IN CONVENTIONAL QSAR STUDIES [J].
CRAMER, RD ;
BUNCE, JD ;
PATTERSON, DE ;
FRANK, IE .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1988, 7 (01) :18-25
[5]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[6]   Free radicals in the physiological control of cell function [J].
Dröge, W .
PHYSIOLOGICAL REVIEWS, 2002, 82 (01) :47-95
[7]   Synthesis and antiviral activity of new pyrazole and thiazole derivatives [J].
El-Sabbagh, Osama I. ;
Baraka, Mohamed M. ;
Ibrahim, Samy M. ;
Pannecouque, Christophe ;
Andrei, Graciela ;
Snoeck, Robert ;
Balzarini, Jan ;
Rashad, Adel A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (09) :3746-3753
[8]   Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline [J].
Girisha, K. S. ;
Kalluraya, Balakrishna ;
Narayana, Vijaya ;
Padmashree .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (10) :4640-4644
[9]   SEVERE ALLOPURINOL TOXICITY - DESCRIPTION AND GUIDELINES FOR PREVENTION IN PATIENTS WITH RENAL-INSUFFICIENCY [J].
HANDE, KR ;
NOONE, RM ;
STONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :47-56
[10]  
Harris MD, 1999, AM FAM PHYSICIAN, V59, P925